Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Graeme R. Quest"'
Autor:
Aaron Polliack, Tamar Tadmor, Brunangelo Falini, James B. Johnston, Judit Demeter, Xavier Troussard, Jae-Hyun Park, Daniel Catovsky, Omar Abdel-Wahab, Alessandro Gozzetti, Versha Banerji, Alan Saven, Monica Else, John F. Seymour, James S. Blachly, Robert J. Kreitman, Constantine S. Tam, Clive S. Zent, Francesco Lauria, Kanti R. Rai, Emili Montserrat, Francesco Forconi, Michael R. Grever, Leslie A. Andritsos, Jacqueline C. Barrientos, Martin S. Tallman, Claire Dearden, Graeme R. Quest, Anthony D. Ho, Eric H. Kraut, Loree Larratt, Gunnar Juliusson, Enrico Tiacci, Sameer A. Parikh, Tadeusz Robak, Timothy G. Call, Pier Luigi Zinzani, Farhad Ravandi, Jeffrey A. Jones, Gerard Lozanski, Thorsten Zenz
Publikováno v:
Blood
Blood, 2017, 129 (5), pp.553-560. ⟨10.1182/blood-2016-01-689422⟩
Blood, American Society of Hematology, 2017, 129 (5), pp.553-560. ⟨10.1182/blood-2016-01-689422⟩
Blood, 2017, 129 (5), pp.553-560. ⟨10.1182/blood-2016-01-689422⟩
Blood, American Society of Hematology, 2017, 129 (5), pp.553-560. ⟨10.1182/blood-2016-01-689422⟩
Hairy cell leukemia is an uncommon hematologic malignancy characterized by pancytopenia and marked susceptibility to infection. Tremendous progress in the management of patients with this disease has resulted in high response rates and improved survi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fdbe5cd134dba2f213cc59d8ba9d3fc
http://hdl.handle.net/11391/1427895
http://hdl.handle.net/11391/1427895
Autor:
Minakshi Taparia, Irwindeep Sandhu, Graeme R. Quest, Lalit Saini, Robert Turner, Elena Liew, Imran Mirza, Bruce Ritchie, Cynthia Wu, Loree Larratt, Sunita Ghosh, Michael J. Mant, Marlene Hamilton, Susan Nahirniak, Lauren Bolster, Jeffery M. Patterson, Nancy Zhu, Anthea Peters, Joseph Brandwein
Publikováno v:
Leukemia research. 45
Most guidelines suggest that only the bone marrow aspirate (BMA) is necessary to assess residual disease following intensive chemotherapy for Acute Myeloid Leukemia (AML) with the bone marrow trephine biopsy (BMTB) recommended in cases of a poor qual
Autor:
James B. Johnston, Graeme R. Quest
Publikováno v:
Best practiceresearch. Clinical haematology. 28(4)
Significant advances in the diagnosis and treatment of hairy cell leukemia (HCL) have recently been made. Improved distinction of HCL from its mimics though clinical presentations, morphologic and immunophenotypic features, and more recently molecula
Publikováno v:
Transfusion. 54(12)
Transfusion-related acute lung injury (TRALI) is a severe transfusion reaction that manifests as acute respiratory compromise within 6 hours of the infusion of blood products. Intravenous immune globulin (IVIG) is prepared from large pools of human p
Autor:
Robert J. Kreitman, Eric H. Kraut, Martin S. Tallman, Anthony D. Ho, Sascha Dietrich, James S. Blachly, Graeme R. Quest, Tamar Tadmor, Judit Demeter, Francesco Lauria, Michael R. Grever, Jacqueline C. Barrientos, Kanti R. Rai, Jeffrey A. Jones, Christopher Heckler, Aaron Polliack, Leslie A. Andritsos, Andrei Fagarasanu, Claire Dearden, Thorsten Zenz, Gunnar Juliusson, Julio Delgado, Enrico Tiacci, Alessandro Gozzetti, Jae H. Park, Monica Else, Mirela Anghelina, Sameer A. Parikh, Nicholas Chiorazzi, Constantine S. Tam, Omkar Lele, Tadeusz Robak, Jan A. Burger, Philip R. O. Payne, Brunangelo Falini, Daniel J. DeAngelo, James B. Johnston, Xavier Troussard, Loree Larratt, Versha Banerji, Pier Luigi Zinzani, Timothy G. Call, Emili Montserrat, Omar Abdel-Wahab, Gerard Lozanski, Farhad Ravandi, Francesco Forconi, Clive S. Zent, Alan Saven
Publikováno v:
Blood. 128:5986-5986
BACKGROUND: The study of rare diseases is limited by the uncommon nature of the conditions as well as the widely dispersed patient populations. Current rare disease registries such as the National Organization of Rare Diseases utilize centralized pla
Autor:
Lauren Bolster, Anthea Peters, Nancy Zhu, Bruce Ritchie, Joseph Brandwein, Robert Turner, Cynthia Wu, Elena Liew, Graeme R. Quest, Sunita Gosh, Lalit Saini, Imran Mirza, Loree Larratt, Michael J. Mant, Irwindeep Sandhu, Jeffery M. Patterson, Marlene Hamilton, Susan Nahirniak
Publikováno v:
Blood. 124:2336-2336
Background: The diagnosis of acute myeloid leukemia (AML), response to treatment and disease recurrence are most commonly assessed with bone marrow studies. Recommendations from leading experts (Bain, 2001) and guidelines of the European LeukemiaNET
Autor:
Michael J. Mant, Lauren Bolster, Nancy Zhu, Marlene Hamilton, Anthea Peters, Joseph Brandwein, Sunita Gosh, Irwindeep Sandhu, Jeffery M. Patterson, Imran Mirza, Robert Turner, Loree Larratt, Graeme R. Quest, Lalit Saini, Elena Liew, Bruce Ritchie, Cynthia Wu
Publikováno v:
Blood. 124:961-961
BACKGROUND: Anthracycline based treatment for acute myeloid leukemia (AML) can be associated with significant morbidity and mortality amongst older patients or those with significant co-morbidities. Furthermore, for patients with previous anthracycli
Autor:
Stephen D. Barr, Macon D. Coleman, James R. Smiley, Jenna N. Kelly, Li S. Xu, Jessica Tong, Graeme R. Quest, Clayton J. Hattlmann, Matthew W. Woods
Publikováno v:
Retrovirology, Vol 8, Iss 1, p 95 (2011)
Microbiology & Immunology Publications
Microbiology & Immunology Publications
Background The identification and characterization of several interferon (IFN)-induced cellular HIV-1 restriction factors, defined as host cellular proteins or factors that restrict or inhibit the HIV-1 life cycle, have provided insight into the IFN